The implementation of self-reported outcome measurements into clinical routine was tested to help facilitate early access to palliative care (PC) for glioblastoma (GBM)-patients. Measures detail PC symptoms and concerns and caregiver burden. Between January 2014 and December 2016, a total of 337 GBM-patients were discussed during meetings of the neuro-oncology tumor board to examine further treatment options. Each patient, along with their caregivers, was requested to participate in self-assessment using the palliative outcome scale (POS) and the Zarit Burden Interview (ZBI). Analyses encompassed summary statistics, non-parametric tests, visual graphic analysis, content analysis and assessing the utilization of the specialized PC consulting...
Carers of people with High Grade Glioma (HGG) completed a survey assessing their anxiety, depression...
OBJECTIVE: Due to the increased demand for palliative care (PC) in recent years, a model has been pr...
Objective: Supportive care needs in glioma patients often remain unrecognized, and optimization in a...
The diagnosis of a brain tumor is a life-changing event for patients and families. High-grade glioma...
BackgroundGlioblastoma is an incurable disease with a poor prognosis. For caregivers of people with ...
Objective: Supportive care needs in glioma patients often remain unrecognized, and optimization in a...
Objective: Supportive care needs in glioma patients often remain unrecognized, and optimization in a...
Abstract BACKGROUND Glioblastoma (GBM) patients fall within NCCN and ASCO guidelines for early palli...
High-grade malignant glioma patients face a poor prognosis, preceded by rapid functional and neurobe...
Objective: Appraise the feasibility of a novel patient reported outcomes (PRO) quality of life (QOL)...
The diagnosis of a brain tumor is a life-changing event for patients and families. High-grade glioma...
Purpose: This study aimed to determine how carer distress and psychological morbidity change over ti...
PURPOSE Gliomas are primary brain tumors with a life-limiting course of disease, and the last wee...
Glioblastoma (GBM) has a median overall survival of 16–21 months. As patients with GBM suffer concur...
INTRODUCTION: Patients with gliomas generally present cognitive, neuropsychiatric and functional def...
Carers of people with High Grade Glioma (HGG) completed a survey assessing their anxiety, depression...
OBJECTIVE: Due to the increased demand for palliative care (PC) in recent years, a model has been pr...
Objective: Supportive care needs in glioma patients often remain unrecognized, and optimization in a...
The diagnosis of a brain tumor is a life-changing event for patients and families. High-grade glioma...
BackgroundGlioblastoma is an incurable disease with a poor prognosis. For caregivers of people with ...
Objective: Supportive care needs in glioma patients often remain unrecognized, and optimization in a...
Objective: Supportive care needs in glioma patients often remain unrecognized, and optimization in a...
Abstract BACKGROUND Glioblastoma (GBM) patients fall within NCCN and ASCO guidelines for early palli...
High-grade malignant glioma patients face a poor prognosis, preceded by rapid functional and neurobe...
Objective: Appraise the feasibility of a novel patient reported outcomes (PRO) quality of life (QOL)...
The diagnosis of a brain tumor is a life-changing event for patients and families. High-grade glioma...
Purpose: This study aimed to determine how carer distress and psychological morbidity change over ti...
PURPOSE Gliomas are primary brain tumors with a life-limiting course of disease, and the last wee...
Glioblastoma (GBM) has a median overall survival of 16–21 months. As patients with GBM suffer concur...
INTRODUCTION: Patients with gliomas generally present cognitive, neuropsychiatric and functional def...
Carers of people with High Grade Glioma (HGG) completed a survey assessing their anxiety, depression...
OBJECTIVE: Due to the increased demand for palliative care (PC) in recent years, a model has been pr...
Objective: Supportive care needs in glioma patients often remain unrecognized, and optimization in a...